Why Cambridge and Oxford spin-outs raise differently from London startups

What to take away

Cambridge and Oxford spin-out funding runs through university IP licensing, grant money and angel syndicates before any venture round appears.
Technology transfer offices at both universities control the licence that investors diligence first, which slows and shapes every term sheet.
Innovate UK grants and UKRI commercialisation funding often pay for the proof that a London startup would fund with equity.
SEIS and EIS are used early and heavily, but the university's equity stake can crowd the cap table and complicate eligibility.
Local angel networks in Cambridge and Oxford write smaller first cheques than London funds, then follow with larger rounds once IP is assigned.
Timelines run longer and dilution is shared differently, because the founding team usually starts with less equity than a London peer.

Why Cambridge and Oxford spin-outs start from a different funding position

A London startup usually begins with founders owning most of the company and a product they can sell. A Cambridge or Oxford spin-out begins with a licence.

The university owns the underlying intellectual property. The founders hold an option or an assignment agreement. That single fact changes who invests, when, and on what terms.

Cambridge's cluster is built on deep tech and life sciences. Oxford's is similar, with a strong therapeutics and quantum base. Both produce companies that need years of lab work before revenue.

That means the first money is rarely a venture round. It is a grant, a proof-of-concept award, or a small angel cheque tied to a milestone in the licence.

In Cambridge and Oxford, the licence terms, not the market, set the pace of the first eighteen months.

Investors who understand this treat the technology transfer office as a co-founder, not a counterparty. Those who do not often walk away at diligence.

For a wider view of how these routes sit alongside other options, see grants and loans.

University IP licensing and technology transfer offices at Cambridge and Oxford

Cambridge Enterprise handles commercialisation for the University of Cambridge. It manages licensing, spin-out formation and the university's equity stake.

Spin-out vs London licence terms

Cambridge/Oxford spin-out

IP ownership: University licence, then assignment
University equity: A few per cent to low teens
Licence fee: Yes
Royalty on sales: Yes
Licence scope: Exclusive for defined field
Negotiation time: Months

London startup

IP ownership: Founder-owned from day one
University equity: None
Licence fee: No
Royalty on sales: No
Licence scope: Not applicable
Negotiation time: Not applicable

Oxford University Innovation does the same job at Oxford. It runs the licence, advises on founding teams and holds the university's shares.

Both offices typically take a licence fee, a royalty on future sales, and a small equity stake. The equity is usually between a few per cent and the low teens.

That stake is the first thing a serious investor checks. It sits on the cap table before any outside money arrives, and it dilutes everyone who follows.

Licences are usually exclusive for a defined field. If the field is drawn too narrowly, the company cannot expand without renegotiating.

Assignment is the other key term. Investors want the IP assigned to the company, not merely licensed, before a priced round.

Both offices have become faster and more standardised, but negotiations still take months. Founders should budget that time into any fundraising plan.

A realistic budget should carry dilution, delay and fallback costs from the licence stage onwards.

What the licence does to a term sheet

Cambridge or Oxford spin-out

IP ownership: University licence, then assignment
University equity: Typically a few per cent to low teens
Royalty: Usually payable on sales
First cheque: Grant, angel or proof-of-concept
Time to priced round: Often twelve to twenty-four months

London startup

IP ownership: Founder-owned from day one
University equity: None
Royalty: None
First cheque: Angel or pre-seed fund
Time to priced round: Often six to twelve months

Innovate UK grants and research commercialisation funding for spin-outs

Grant money is the second pillar of Cambridge and Oxford spin-out funding. It pays for work that equity investors would rather not fund.

Innovate UK offers Smart grants, innovation loans and sector-specific competitions. Spin-outs use these to reach technical milestones before a priced round.

Smart grants typically cover total project costs of £100,000 to £2 million, with funding rates up to 70% for small companies.

The advantage is that grants do not dilute. The disadvantage is timing, reporting and the fact that grant-funded work must stay within the funded project.

Research commercialisation routes include proof-of-concept and translation funding, which are the routes most Cambridge and Oxford spin-outs actually use.

Applications go through the UKRI funding hub, which lists competitions and eligibility. Founders should treat this as a pipeline, not a one-off application.

A typical sequence is a small proof-of-concept grant, then a larger Innovate UK grant, then an angel round. Each stage de-risks the next.

Grant income also affects how investors read the company. It signals that an independent panel has reviewed the science.

Compare this with London, where grant use is lower and equity is raised earlier.

How SEIS and EIS are used in university spin-out rounds

SEIS and EIS are the tax-advantaged routes that make early spin-out rounds investable for angels. Both are administered by HM Revenue & Customs.

SEIS vs EIS for spin-out rounds

SEIS

Stage: Earliest stage
Relief: Most generous
Company requirement: New and unquoted
Holding period: Minimum period applies
Advance assurance: Apply to HMRC first

EIS

Stage: Larger later rounds
Relief: Relief on subscriptions
Company requirement: Must qualify
Holding period: Minimum period applies
Advance assurance: Apply to HMRC first

SEIS applies to the earliest stage. It gives investors 50% income tax relief, and the company can raise up to £250,000 over its lifetime. The company must be new, unquoted and within the scheme's limits.

EIS applies to larger later rounds. It gives 30% income tax relief, and a company can raise up to £5 million per tax year, with a £12 million lifetime limit, or £20 million for knowledge-intensive companies. Investors can claim relief on subscriptions for shares, provided the company qualifies and the shares are held for the minimum period.

Advance assurance matters. Founders should apply to HMRC before opening a round, because the university's equity stake and any convertible loans can affect eligibility.

A common structure is a small SEIS round to fund the first experiments, followed by an EIS round once the licence is assigned and the company has a clear plan.

The rules on eligibility and limits are set out in the official guidance for the Seed Enterprise Investment Scheme and for the Enterprise Investment Scheme.

Two practical points recur. First, the university's stake must be structured so it does not breach the rules. Second, convertible notes can create problems if they are not converted before the EIS round.

Angels in both clusters know these rules well.

It also helps to check eligibility to the whole bargain before choosing between grant, SEIS and EIS money.

Local angel networks compared with London deal norms

Cambridge and Oxford have dense, specialist angel networks, including Cambridge Angels and the Oxford Investment Opportunity Network (OION). London has more capital, but it is spread across many sectors.

In Cambridge, angels cluster around life sciences, deep tech and software. Many are former founders or executives from the same cluster, and they invest close to home.

Oxford's network is similar, with strength in therapeutics, quantum and engineering. University-linked funds such as Cambridge Innovation Capital and Oxford Science Enterprises, plus college endowments, also participate.

These angels typically write first cheques of £10,000 to £50,000, smaller than London funds. They are also more willing to accept a longer path to revenue, because they understand the science.

In Cambridge and Oxford, the first meeting is often about the licence and the science. The term sheet comes later, after technical milestones.

That difference shows up in round sizes. A first angel or SEIS round in either cluster is typically £100,000 to £250,000, then a larger round follows once the technology is validated.

Syndication is common. A lead angel brings in others, and the university may introduce investors through its network.

The trade-off is clear. Local angels are patient and informed, but they cannot match London's cheque sizes alone. Founders often blend local angels with London or international funds at the next stage.

For a side-by-side comparison of the instruments involved, see Grants, Start Up Loans.

Ticket sizes, timelines and dilution in Cambridge and Oxford versus London

Ticket sizes differ most at the earliest stage. Cambridge and Oxford spin-outs often raise first rounds of £100,000 to £250,000, because grants and angels carry the early risk. London pre-seed rounds typically range from £250,000 to £1.5 million.

London pre-seed rounds dilute founders earlier. The London model trades ownership for speed.

The spin-out model trades speed for ownership.

Timelines reflect this. A Cambridge or Oxford spin-out may take a year or more to reach a priced round. A London startup might do it in half that time.

Dilution is shared differently too. The university's stake, the licence royalty and any grant-funded work all sit alongside the founders' equity.

Investors should model the full cap table, not just the round. A small university stake can become significant after two or three rounds.

Founders should also track how grant milestones affect the next raise. The five layers of funding measurement cover these milestones.

A real example: Oxford Nanopore Technologies

Oxford Nanopore Technologies was spun out of the University of Oxford in 2005. It raised an initial £7.5 million venture round that year.

Oxford Nanopore Technologies

The company used grant funding and early venture money to develop its sequencing technology.
It raised a £100 million round in 2014 to scale commercial operations.
The university retained an equity stake through Oxford University Innovation.
It listed on the London Stock Exchange in 2021.

A London startup might reach a comparable stage in fewer rounds. The spin-out took longer, but the founders and the university shared the early risk.

Checklist before opening a spin-out round

Confirm the licence terms and the assignment trigger with the technology transfer office.
Apply for HMRC advance assurance for SEIS or EIS before approaching investors.
Check Innovate UK and UKRI competitions for non-dilutive funding that fits the next milestone.
Map the full cap table, including the university stake and any convertible loans.
Line up a lead angel from the local network before going to London funds.
Budget for a longer timeline than a comparable London startup.

Common questions

Why do Cambridge and Oxford spin-outs raise differently from London startups?

Because the university owns the underlying IP. Grants and specialist angels also shape the early terms before any venture round.

Which technology transfer offices handle Cambridge and Oxford spin-outs?

Cambridge Enterprise handles the University of Cambridge, and Oxford University Innovation handles Oxford. Both manage licensing, spin-out formation and the university's equity stake.

Can a spin-out use both SEIS and EIS?

Yes, in sequence. SEIS usually funds the earliest stage, and EIS follows once the company qualifies and the IP is assigned. Advance assurance from HMRC is advisable before either round.

How do Innovate UK grants fit into a spin-out round?

They fund technical milestones that would otherwise need equity. A common pattern is a proof-of-concept grant, then a larger Innovate UK grant, then an angel round.

Are Cambridge and Oxford angel networks different from London funds?

They write smaller first cheques and are more patient with deep tech and life sciences. London funds often want more traction and a larger market.

How long does a spin-out round take compared with London?

A Cambridge or Oxford spin-out often takes twelve to twenty-four months to reach a priced round. A comparable London startup may take six to twelve months.